Cannara Biotech (8CB0) Ownership - Who Owns Cannara Biotech?
0 Followers
Cannara Biotech (8CB0) Ownership Overview
- 75.64% Insiders
- 0.27% ETFs
- 24.09% Public Companies and Individual Investors
The ownership structure of Cannara Biotech (DE:8CB0) stock is a mix of institutional, retail, and individual investors. Approximately 0.27% of the company’s stock is owned by Institutional Investors, 75.64% is owned by Insiders, and 24.09% is owned by Public Companies and Individual Investors.
The ownership structure of Cannara Biotech (DE:8CB0) stock is a mix of institutional, retail, and individual investors. Approximately 0.27% of the company’s stock is owned by Institutional Investors, 75.64% is owned by Insiders, and 24.09% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Jul 31, 2026 | Olymbec Investments Inc. | C$96,500 | |
| Jun 08, 2026 | Nicholas Sosiak | C$28,560 | |
| Mar 06, 2026 | Donald John Olds | C$5,250 | |
| Mar 06, 2026 | Donald John Olds | C$2,052 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Zohar Krivorot | 25,185,874 | Insider | 25.50% | 36,972,863 |
| Olymbec Investments Inc. | 23,842,920 | Insider | 24.14% | 35,001,407 |
| Derek Elan Stern | 23,793,560 | Insider | 24.09% | 34,928,946 |
| Donald John Olds | 830,022 | Insider | 0.84% | 1,218,472 |
| Nicholas Sosiak | 821,715 | Insider | 0.83% | 1,206,278 |
| Advisorshares | 263,379 | Institution | 0.27% | 386,640 |
| Jack Moses Kay | 234,000 | Insider | 0.24% | 343,512 |
| Mary Durocher | 15,000 | Insider | 0.02% | 22,020 |
FAQ
Who Owns Cannara Biotech (DE:8CB0)?
According to the latest TipRanks data, approximately 0.27% of the company's stock is held by institutional investors, 75.64% is held by insiders, and 24.09% is held by public companies and individual investors.
What percentage of Cannara Biotech (DE:8CB0) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.27% of Cannara Biotech (DE:8CB0) stock is held by institutional investors.
What percentage of Cannara Biotech (DE:8CB0) stock is held by retail investors?
According to the latest TipRanks data, approximately 24.09% of Cannara Biotech (DE:8CB0) stock is held by public companies and individual investors.
Who owns the most shares of Cannara Biotech (DE:8CB0)?
Zohar Krivorot owns the most shares of Cannara Biotech (DE:8CB0).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
